| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.
|
Diabetes Care
|
2011
|
5.63
|
|
2
|
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
|
J Clin Oncol
|
2007
|
4.45
|
|
3
|
Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer.
|
Nat Genet
|
2009
|
2.85
|
|
4
|
Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
|
Am J Surg Pathol
|
2006
|
2.34
|
|
5
|
The Y deletion gr/gr and susceptibility to testicular germ cell tumor.
|
Am J Hum Genet
|
2005
|
2.26
|
|
6
|
Comparison of objective and patient-reported hot flash measures in men with prostate cancer.
|
J Support Oncol
|
2009
|
2.20
|
|
7
|
Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.
|
J Clin Oncol
|
2010
|
2.18
|
|
8
|
American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.
|
J Clin Oncol
|
2010
|
2.14
|
|
9
|
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
|
J Clin Oncol
|
2006
|
2.09
|
|
10
|
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.
|
J Natl Cancer Inst
|
2012
|
1.69
|
|
11
|
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.
|
Eur Urol
|
2012
|
1.66
|
|
12
|
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.
|
Eur Urol
|
2012
|
1.64
|
|
13
|
A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.61
|
|
14
|
Treatment of growing teratoma syndrome.
|
N Engl J Med
|
2009
|
1.43
|
|
15
|
A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.
|
Hum Mol Genet
|
2011
|
1.34
|
|
16
|
An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.
|
Cancer
|
2013
|
1.05
|
|
17
|
Adult type granulosa cell tumor in adult testis: report of a case and review of the literature.
|
Rare Tumors
|
2011
|
0.95
|
|
18
|
Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.
|
Cancer
|
2013
|
0.94
|
|
19
|
Complications associated with chemotherapy in testicular cancer management.
|
Nat Rev Urol
|
2011
|
0.94
|
|
20
|
Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.90
|
|
21
|
A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinoma.
|
Cancer
|
2005
|
0.90
|
|
22
|
Interest in services among prostate cancer patients receiving androgen deprivation therapy.
|
Psychooncology
|
2004
|
0.89
|
|
23
|
A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors.
|
Invest New Drugs
|
2013
|
0.86
|
|
24
|
Testicular seminoma 16 years after treatment for CNS germinoma.
|
J Neurooncol
|
2004
|
0.85
|
|
25
|
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.85
|
|
26
|
HIF transcription factor expression and induction of hypoxic response genes in a retroperitoneal angiosarcoma.
|
Anticancer Res
|
2004
|
0.85
|
|
27
|
Thromboembolic events with estramustine phosphate-based chemotherapy in patients with hormone-refractory prostate carcinoma: results of a meta-analysis.
|
Cancer
|
2004
|
0.84
|
|
28
|
Third-line chemotherapy and novel agents for metastatic germ cell tumors.
|
Hematol Oncol Clin North Am
|
2011
|
0.82
|
|
29
|
Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).
|
Front Endocrinol (Lausanne)
|
2012
|
0.81
|
|
30
|
PD0332991 (palbociclib) for treatment of pediatric intracranial growing teratoma syndrome.
|
Pediatr Blood Cancer
|
2014
|
0.79
|
|
31
|
Hypogonadism and infertility in testicular cancer survivors.
|
J Natl Compr Canc Netw
|
2012
|
0.79
|
|
32
|
Phase II trial of 5-fluorouracil and leucovorin in combination with interferon-alpha and interleukin-2 for advanced renal cell cancer.
|
Am J Clin Oncol
|
2004
|
0.78
|
|
33
|
Increases in core body temperature precede hot flashes in a prostate cancer patient.
|
Psychooncology
|
2009
|
0.78
|
|
34
|
Health behaviors among testicular cancer survivors.
|
J Community Support Oncol
|
2014
|
0.77
|
|
35
|
Cardiovascular late effects and the ongoing care of adult cancer survivors.
|
Dis Manag
|
2008
|
0.77
|
|
36
|
Phase I study of weekly liposome-encapsulated doxorubicin in patients with advanced, androgen-independent prostate cancer.
|
Am J Clin Oncol
|
2004
|
0.77
|
|
37
|
Phase II clinical trial of oxaliplatin and bevacizumab in refractory germ cell tumors.
|
Am J Clin Oncol
|
2014
|
0.77
|
|
38
|
Cancer survivorship research: the best is yet to come.
|
J Clin Oncol
|
2002
|
0.77
|
|
39
|
Pilot trial of adjuvant paclitaxel plus estramustine in resected high-risk prostate cancer.
|
Urology
|
2008
|
0.77
|
|
40
|
Chemotherapy for patients with poor prognosis germ cell tumors.
|
World J Urol
|
2009
|
0.77
|
|
41
|
Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
|
Can J Urol
|
2010
|
0.77
|
|
42
|
Granulomatosis and testicular germ cell tumors.
|
Urology
|
2012
|
0.77
|
|
43
|
Vinflunine in the treatment of advanced bladder cancer.
|
Expert Rev Anticancer Ther
|
2011
|
0.75
|
|
44
|
Comparison of address-based sampling and random-digit dialing methods for recruiting young men as controls in a case-control study of testicular cancer susceptibility.
|
Am J Epidemiol
|
2013
|
0.75
|
|
45
|
Moving forward in advanced bladder cancer.
|
J Clin Oncol
|
2007
|
0.75
|
|
46
|
Poor-prognosis germ cell tumors: we have not yet crossed the finish line.
|
J Clin Oncol
|
2007
|
0.75
|
|
47
|
Editorial comment on "Late relapse of testicular germ cell tumors".
|
Urol Oncol
|
2005
|
0.75
|
|
48
|
Somatic genetic changes in association with testicular germ cell tumor prognosis.
|
Cancer Biol Ther
|
2004
|
0.75
|
|
49
|
Transrectal radiofrequency ablation for pelvic recurrence of bladder cancer: case report and review of complications.
|
J Vasc Interv Radiol
|
2005
|
0.75
|
|
50
|
Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285).
|
Oncology
|
2004
|
0.75
|
|
51
|
Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications.
|
Oncol Nurs Forum
|
2005
|
0.75
|
|
52
|
In the clinic. Care of the adult cancer survivor.
|
Ann Intern Med
|
2013
|
0.75
|